Mr Scrna Research Plannerv0.1.0

A biomedical research lab at a university wants to design a computational study investigating the causal role of ferroptosis genes in diabetic nephropathy using public GWAS and scRNA-seq datasets. They need a structured plan to apply for grants or initiate a paper, focusing on causal biomarkers with a Standard workload configuration.

A biotech company aims to identify druggable targets for obesity-related osteoarthritis by analyzing synovial cell states through MR and scRNA-seq. They require an Advanced or Publication+ plan to prioritize candidate genes and validate mechanisms for drug development pipelines, leveraging multi-dataset integration.

A core facility in a hospital or research institute uses this skill to generate custom research designs for clients studying immune senescence in pulmonary fibrosis. They offer Lite to Publication+ configurations as scalable services, helping researchers plan MR + scRNA-seq studies with step-by-step workflows.

A PhD student in computational biology needs to design a study on pyroptosis-related genes in colorectal cancer for their dissertation. They use the skill to create a Lite or Standard plan with public data, focusing on key-cell identification and causal validation to ensure a feasible, publishable project.

Offer access to the skill via a subscription platform where users input study parameters to generate customized research designs. Revenue comes from tiered plans (e.g., Lite free, paid for Advanced/Publication+ features), targeting academic and industry researchers.

Provide expert consulting to organizations needing tailored MR + scRNA-seq study designs, including workflow implementation and tool integration. Revenue is generated through project-based fees or retainer contracts for ongoing support.

Host workshops and online courses teaching researchers how to use the skill for designing studies, covering patterns like mechanism gene-set or key-cell driven analyses. Revenue comes from enrollment fees and certification programs.